North America (US, Canada and Mexico) ALL Vaccine Market Report 2017

Published by: | Published Date: April, 2017 | Number of pages: 126

$4,099$8,198

the United States ALL Vaccine market is valued at XX USD million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

The Canada ALL Vaccine market is valued at XX USD million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

And Mexico ALL Vaccine market is valued at XX USD million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits North America into three countries, with sales (volume), revenue (value), market share and growth rate of ALL Vaccine in these regions, from 2012 to 2022 (forecast), covering
United States
Canada
Mexico

The major players in North America market include Pfizer, Inc., Glaxosmithkline, PLC., Merck & Co., Inc., Novarits, Sanofi Pasteur, CSL Limited, Emergent Biosolutions, Inc., Johnson & Johnson, Medimmune, LLC. (A Subsidiary of Astrazeneca), Astellas Pharma Inc., Mitsubishi Tanabe, Dynavax Technologies, Novavax

On the basis of product, the ALL Vaccine market is primarily split into
Vaccinia
Measles, mumps, rubella
Varicella
Influenza
Rotavirus
Zoster
Yellow Fever
Polio
Hepatitis A
Rabies
BCG
Diphtheria, tetanus
Hepatitis B
Haemophilus influenzae type b
Pertussis
Human papillomavirus
Meningococcal
Pneumococcal

On the basis on the end users/applications, this report covers
For Adult
For Child

Clear
SKU: QY231419 Category:
Table of Contents

North America (US, Canada and Mexico) ALL Vaccine Market Report 2017
1 ALL Vaccine Overview
1.1 Product Overview and Scope of ALL Vaccine
1.2 Classification of ALL Vaccine by Product Category
1.2.1 North America ALL Vaccine Sales (K Units) Comparison by Types (2012-2022)
1.2.2 North America ALL Vaccine Sales (K Units) Market Share by Types in 2016
1.2.3 Vaccinia
1.2.4 Measles, mumps, rubella
1.2.5 Varicella
1.2.6 Influenza
1.2.7 Rotavirus
1.2.8 Zoster
1.2.9 Yellow Fever
1.2.10 Polio
1.2.11 Hepatitis A
1.2.12 Rabies
1.2.13 BCG
1.2.14 Diphtheria, tetanus
1.2.15 Hepatitis B
1.2.16 Haemophilus influenzae type b
1.2.17 Pertussis
1.2.18 Human papillomavirus
1.2.19 Meningococcal
1.2.20 Pneumococcal
1.3 North America ALL Vaccine Market by Applications/End Users
1.3.1 North America ALL Vaccine Sales (K Units) and Market Share Comparison by Applications (2012-2022)
1.3.2 For Adult
1.3.3 For Child
1.3.4 Application 3
1.3.5 Application 4
1.3.6 Application 5
1.4 North America ALL Vaccine Revenue (Million USD) (2012-2022)
1.4.1 North America ALL Vaccine Revenue (Million USD) Comparison (2012-2022)
1.4.2 United States ALL Vaccine Status and Prospect (2012-2022)
1.4.3 Canada ALL Vaccine Status and Prospect (2012-2022)
1.4.4 Mexico ALL Vaccine Status and Prospect (2012-2022)
1.5 North America ALL Vaccine Sales (2012-2022)
1.5.1 North America ALL Vaccine Sales Comparison (2012-2022)
1.5.2 United States ALL Vaccine Sales (K Units) and Growth Rate (%) (2012-2022)
1.5.3 Canada ALL Vaccine Sales (K Units) and Growth Rate (%) (2012-2022)
1.5.4 Mexico ALL Vaccine Sales (K Units) and Growth Rate (%) (2012-2022)
2 United States ALL Vaccine Market Competition by Players/Manufacturers
2.1 United States ALL Vaccine Sales (K Units) and Market Share (%) by Key Players/Manufacturers (2012-2017)
2.2 United States ALL Vaccine Revenue (Million USD) and Market Share (%) by Players/Manufacturers (2012-2017)
2.3 United States ALL Vaccine Average Price (USD/Unit) by Players/Manufacturers (2012-2017)
2.4 United States ALL Vaccine Market Competitive Situation and Trends
2.4.1 United States ALL Vaccine Market Concentration Rate
2.4.2 United States ALL Vaccine Market Share (%) of Top 3 and Top 5 Players/Manufacturers
2.5 United States Players/Manufacturers ALL Vaccine Manufacturing Base Distribution, Sales Area, Product Types
3 Canada ALL Vaccine Market Competition by Players/Manufacturers
3.1 Canada ALL Vaccine Sales and Market Share (%) of Key Players/Manufacturers (2012-2017)
3.2 Canada ALL Vaccine Revenue (Million USD) and Market Share (%) by Players/Manufacturers (2012-2017)
3.3 Canada ALL Vaccine Average Price (USD/Unit) by Players/Manufacturers (2012-2017)
3.4 Canada ALL Vaccine Market Competitive Situation and Trends
3.4.1 Canada ALL Vaccine Market Concentration Rate
3.4.2 Canada ALL Vaccine Market Share (%) of Top 3 and Top 5 Players/Manufacturers
3.5 Canada Players/Manufacturers ALL Vaccine Manufacturing Base Distribution, Sales Area, Product Types
4 Mexico ALL Vaccine Market Competition by Players/Manufacturers
4.1 Mexico ALL Vaccine Sales and Market Share (%) of Key Players/Manufacturers (2012-2017)
4.2 Mexico ALL Vaccine Revenue (Million USD) and Market Share (%) by Players/Manufacturers (2012-2017)
4.3 Mexico ALL Vaccine Average Price (USD/Unit) by Players/Manufacturers (2012-2017)
4.4 Mexico ALL Vaccine Market Competitive Situation and Trends
4.4.1 Mexico ALL Vaccine Market Concentration Rate
4.4.2 Mexico ALL Vaccine Market Share (%) of Top 3 and Top 5 Players/Manufacturers
4.5 Mexico Players/Manufacturers ALL Vaccine Manufacturing Base Distribution, Sales Area, Product Types
5 North America ALL Vaccine Sales and Revenue by Type (2012-2017)
5.1 North America ALL Vaccine Sales (K Units) and Market Share (%) by Type (2012-2017)
5.2 North America ALL Vaccine Revenue (Million USD) and Market Share (%) by Type (2012-2017)
5.3 North America ALL Vaccine Price by Type (2012-2017)
5.4 North America ALL Vaccine Sales Growth Rate (%) by Type (2012-2017)
6 North America ALL Vaccine Sales (Volume) by Application (2012-2017)
6.1 North America ALL Vaccine Sales (K Units) and Market Share (%) by Applications (2012-2017)
6.2 North America ALL Vaccine Sales Growth Rate (%) by Applications (2012-2017)
6.3 Market Drivers and Opportunities
7 North America ALL Vaccine Players/Manufacturers Profiles and Sales Data
7.1 Pfizer, Inc.
7.1.1 Company Basic Information, Manufacturing Base and Competitors
7.1.2 ALL Vaccine Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Pfizer, Inc. ALL Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
7.1.4 Main Business/Business Overview
7.2 Glaxosmithkline, PLC.
7.2.1 Company Basic Information, Manufacturing Base and Competitors
7.2.2 ALL Vaccine Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Glaxosmithkline, PLC. ALL Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
7.2.4 Main Business/Business Overview
7.3 Merck & Co., Inc.
7.3.1 Company Basic Information, Manufacturing Base and Competitors
7.3.2 ALL Vaccine Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Merck & Co., Inc. ALL Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
7.3.4 Main Business/Business Overview
7.4 Novarits
7.4.1 Company Basic Information, Manufacturing Base and Competitors
7.4.2 ALL Vaccine Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Novarits ALL Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
7.4.4 Main Business/Business Overview
7.5 Sanofi Pasteur
7.5.1 Company Basic Information, Manufacturing Base and Competitors
7.5.2 ALL Vaccine Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Sanofi Pasteur ALL Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
7.5.4 Main Business/Business Overview
7.6 CSL Limited
7.6.1 Company Basic Information, Manufacturing Base and Competitors
7.6.2 ALL Vaccine Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.6.3 CSL Limited ALL Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
7.6.4 Main Business/Business Overview
7.7 Emergent Biosolutions, Inc.
7.7.1 Company Basic Information, Manufacturing Base and Competitors
7.7.2 ALL Vaccine Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Emergent Biosolutions, Inc. ALL Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
7.7.4 Main Business/Business Overview
7.8 Johnson & Johnson
7.8.1 Company Basic Information, Manufacturing Base and Competitors
7.8.2 ALL Vaccine Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 Johnson & Johnson ALL Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
7.8.4 Main Business/Business Overview
7.9 Medimmune, LLC. (A Subsidiary of Astrazeneca)
7.9.1 Company Basic Information, Manufacturing Base and Competitors
7.9.2 ALL Vaccine Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 Medimmune, LLC. (A Subsidiary of Astrazeneca) ALL Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
7.9.4 Main Business/Business Overview
7.10 Astellas Pharma Inc.
7.10.1 Company Basic Information, Manufacturing Base and Competitors
7.10.2 ALL Vaccine Product Category, Application and Specification
7.10.2.1 Product A
7.10.2.2 Product B
7.10.3 Astellas Pharma Inc. ALL Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
7.10.4 Main Business/Business Overview
7.11 Mitsubishi Tanabe
7.12 Dynavax Technologies
7.13 Novavax
8 ALL Vaccine Manufacturing Cost Analysis
8.1 ALL Vaccine Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of ALL Vaccine
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 ALL Vaccine Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of ALL Vaccine Major Players/Manufacturers in 2015
9.4 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
12 North America ALL Vaccine Sales and Revenue Forecast (2017-2022)
12.1 United States ALL Vaccine Sales (K Units) and Revenue (Million USD) Forecast (2017-2022)
12.2 Canada ALL Vaccine Sales (K Units) and Revenue (Million USD) Forecast (2017-2022)
12.3 Mexico ALL Vaccine Sales (K Units) and Revenue (Million USD) Forecast (2017-2022)
12.4 North America ALL Vaccine Sales (K Units) Forecast by Type (2017-2022)
12.5 North America ALL Vaccine Sales (K Units) Forecast by Application (2017-2022)
13 Research Findings and Conclusion
14 Methodology and Data Source
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
14.4 Author List

Request Data
List of Tables and Figures

Table North America Market ALL Vaccine Revenue (Million USD) Comparison by Regions 2012-2022
Table North America ALL Vaccine Sales (K Units) and Revenue (Million USD) Market Split by Product Type
Table North America ALL Vaccine Sales (K Units) by Application (2016-2022)
Figure Product Picture of ALL Vaccine
Table North America ALL Vaccine Sales (K Units) and Growth Rate (%) Comparison by Types (2012-2022)
Figure North America ALL Vaccine Sales Market Share (%) by Types in 2016
Figure Vaccinia Product Picture
Figure Measles, mumps, rubella Product Picture
Figure Varicella Product Picture
Figure Influenza Product Picture
Figure Rotavirus Product Picture
Table North America ALL Vaccine Sales (K Units) Comparison by Applications (2012-2022)
Figure North America Sales Market Share (%) of ALL Vaccine by Applications in 2016
Figure For Adult Examples
Figure For Child Examples
Figure Application 3 Examples
Figure Application 4 Examples
Figure Application 5 Examples
Figure United States ALL Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Canada ALL Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Mexico ALL Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure North America ALL Vaccine Sales (K Units) and Growth Rate (%) (2012-2022)
Figure United States ALL Vaccine Sales (K Units) and Growth Rate (%) (2012-2022)
Figure Canada ALL Vaccine Sales (K Units) and Growth Rate (%) (2012-2022)
Figure Mexico ALL Vaccine Sales (K Units) and Growth Rate (%) (2012-2022)
Table United States ALL Vaccine Sales (K Units) by Key Players/Manufacturers (2012-2017)
Table United States ALL Vaccine Sales Market Share (%) by Players/Manufacturers (2012-2017)
Figure 2016 United States ALL Vaccine Sales Market Share (%) by Players/Manufacturers
Figure 2017 United States ALL Vaccine Sales Market Share (%) by Players/Manufacturers
Table United States ALL Vaccine Revenue (Million USD) by Players/Manufacturers (2012-2017)
Table United States ALL Vaccine Revenue Share (%) by Players/Manufacturers (2012-2017)
Figure 2016 United States ALL Vaccine Revenue Share (%) by Players/Manufacturers
Figure 2017 United States ALL Vaccine Revenue Share (%) by Players/Manufacturers
Table United States Market ALL Vaccine Average Price (USD/Unit) of Key Players/Manufacturers (2012-2017)
Figure United States Market ALL Vaccine Average Price (USD/Unit) of Key Players/Manufacturers in 2016
Figure United States ALL Vaccine Market Share (%) of Top 3 Players/Manufacturers
Figure United States ALL Vaccine Market Share (%) of Top 5 Players/Manufacturers
Table United States Players/Manufacturers ALL Vaccine Manufacturing Base Distribution and Sales Area
Table United States Players/Manufacturers ALL Vaccine Product Category
Table Canada ALL Vaccine Sales (K Units) by Key Players/Manufacturers (2012-2017)
Table Canada ALL Vaccine Sales Market Share (%) by Players/Manufacturers (2012-2017)
Figure 2016 Canada ALL Vaccine Sales Market Share (%) by Players/Manufacturers
Figure 2017 Canada ALL Vaccine Sales Market Share (%) by Players/Manufacturers
Table Canada ALL Vaccine Revenue (Million USD) by Players/Manufacturers (2012-2017)
Table Canada ALL Vaccine Revenue Share (%) by Players/Manufacturers (2012-2017)
Figure 2016 Canada ALL Vaccine Revenue Share (%) by Players/Manufacturers
Figure 2017 Canada ALL Vaccine Revenue Share (%) by Players/Manufacturers
Table Canada Market ALL Vaccine Average Price (USD/Unit) of Key Players/Manufacturers (2012-2017)
Figure Canada Market ALL Vaccine Average Price (USD/Unit) of Key Players/Manufacturers in 2016
Figure 2016 Canada ALL Vaccine Market Share (%) of Top 3 Players/Manufacturers
Figure 2016 Canada ALL Vaccine Market Share (%) of Top 5 Players/Manufacturers
Table Canada Players/Manufacturers ALL Vaccine Manufacturing Base Distribution and Sales Area
Table Canada Players/Manufacturers ALL Vaccine Product Category
Table Mexico ALL Vaccine Sales (K Units) by Key Players/Manufacturers (2012-2017)
Table Mexico ALL Vaccine Sales Market Share (%) by Players/Manufacturers (2012-2017)
Figure 2016 Mexico ALL Vaccine Sales Market Share (%) by Players/Manufacturers
Figure 2017 Mexico ALL Vaccine Sales Market Share (%) by Players/Manufacturers
Table Mexico ALL Vaccine Revenue (Million USD) by Players/Manufacturers (2012-2017)
Table Mexico ALL Vaccine Revenue Share (%) by Players/Manufacturers (2012-2017)
Figure 2016 Mexico ALL Vaccine Revenue Share (%) by Players/Manufacturers
Figure 2017 Mexico ALL Vaccine Revenue Share (%) by Players/Manufacturers
Table Mexico Market ALL Vaccine Average Price (USD/Unit) of Key Players/Manufacturers (2012-2017)
Figure Mexico Market ALL Vaccine Average Price (USD/Unit) of Key Players/Manufacturers in 2016
Figure Mexico ALL Vaccine Market Share (%) of Top 3 Players/Manufacturers
Figure Mexico ALL Vaccine Market Share (%) of Top 5 Players/Manufacturers
Table Mexico Players/Manufacturers ALL Vaccine Manufacturing Base Distribution and Sales Area
Table Mexico Players/Manufacturers ALL Vaccine Product Category
Table North America ALL Vaccine Sales (K Units) by Type (2012-2017)
Table North America ALL Vaccine Sales Market Share (%) by Type (2012-2017)
Figure North America ALL Vaccine Sales Market Share (%) by Type (2012-2017)
Figure North America ALL Vaccine Sales Market Share (%) by Type in 2016
Table North America ALL Vaccine Revenue (Million USD) and Market Share (%) by Type (2012-2017)
Table North America ALL Vaccine Revenue Share (%) by Type (2012-2017)
Figure Revenue Market Share (%) of ALL Vaccine by Type (2012-2017)
Figure Revenue Market Share (%) of ALL Vaccine by Type in 2016
Table North America ALL Vaccine Price by Types (2012-2017)
Figure North America ALL Vaccine Sales Growth Rate (%) by Type (2012-2017)
Table North America ALL Vaccine Sales (K Units) by Applications (2012-2017)
Table North America ALL Vaccine Sales Market Share (%) by Applications (2012-2017)
Figure North America ALL Vaccine Sales Market Share (%) by Applications (2012-2017)
Figure North America ALL Vaccine Sales Market Share (%) by Applications in 2016
Table North America ALL Vaccine Sales Growth Rate (%) by Applications (2012-2017)
Figure North America ALL Vaccine Sales Growth Rate (%) by Applications (2012-2017)
Table Pfizer, Inc. Basic Information List
Table Pfizer, Inc. ALL Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Pfizer, Inc. ALL Vaccine Sales Growth Rate (%) (2012-2017)
Figure Pfizer, Inc. ALL Vaccine Sales Market Share (%) in North America (2012-2017)
Figure Pfizer, Inc. ALL Vaccine Revenue Market Share (%) in North America (2012-2017)
Table Glaxosmithkline, PLC. Basic Information List
Table Glaxosmithkline, PLC. ALL Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Glaxosmithkline, PLC. ALL Vaccine Sales Growth Rate (%) (2012-2017)
Figure Glaxosmithkline, PLC. ALL Vaccine Sales Market Share (%) in North America (2012-2017)
Figure Glaxosmithkline, PLC. ALL Vaccine Revenue Market Share (%) in North America (2012-2017)
Table Merck & Co., Inc. Basic Information List
Table Merck & Co., Inc. ALL Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Merck & Co., Inc. ALL Vaccine Sales Growth Rate (%) (2012-2017)
Figure Merck & Co., Inc. ALL Vaccine Sales Market Share (%) in North America (2012-2017)
Figure Merck & Co., Inc. ALL Vaccine Revenue Market Share (%) in North America (2012-2017)
Table Novarits Basic Information List
Table Novarits ALL Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Novarits ALL Vaccine Sales Growth Rate (%) (2012-2017)
Figure Novarits ALL Vaccine Sales Market Share (%) in North America (2012-2017)
Figure Novarits ALL Vaccine Revenue Market Share (%) in North America (2012-2017)
Table Sanofi Pasteur Basic Information List
Table Sanofi Pasteur ALL Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Sanofi Pasteur ALL Vaccine Sales Growth Rate (%) (2012-2017)
Figure Sanofi Pasteur ALL Vaccine Sales Market Share (%) in North America (2012-2017)
Figure Sanofi Pasteur ALL Vaccine Revenue Market Share (%) in North America (2012-2017)
Table CSL Limited Basic Information List
Table CSL Limited ALL Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure CSL Limited ALL Vaccine Sales Growth Rate (%) (2012-2017)
Figure CSL Limited ALL Vaccine Sales Market Share (%) in North America (2012-2017)
Figure CSL Limited ALL Vaccine Revenue Market Share (%) in North America (2012-2017)
Table Emergent Biosolutions, Inc. Basic Information List
Table Emergent Biosolutions, Inc. ALL Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Emergent Biosolutions, Inc. ALL Vaccine Sales Growth Rate (%) (2012-2017)
Figure Emergent Biosolutions, Inc. ALL Vaccine Sales Market Share (%) in North America (2012-2017)
Figure Emergent Biosolutions, Inc. ALL Vaccine Revenue Market Share (%) in North America (2012-2017)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson ALL Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Johnson & Johnson ALL Vaccine Sales Growth Rate (%) (2012-2017)
Figure Johnson & Johnson ALL Vaccine Sales Market Share (%) in North America (2012-2017)
Figure Johnson & Johnson ALL Vaccine Revenue Market Share (%) in North America (2012-2017)
Table Medimmune, LLC. (A Subsidiary of Astrazeneca) Basic Information List
Table Medimmune, LLC. (A Subsidiary of Astrazeneca) ALL Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Medimmune, LLC. (A Subsidiary of Astrazeneca) ALL Vaccine Sales Growth Rate (%) (2012-2017)
Figure Medimmune, LLC. (A Subsidiary of Astrazeneca) ALL Vaccine Sales Market Share (%) in North America (2012-2017)
Figure Medimmune, LLC. (A Subsidiary of Astrazeneca) ALL Vaccine Revenue Market Share (%) in North America (2012-2017)
Table Astellas Pharma Inc. Basic Information List
Table Astellas Pharma Inc. ALL Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017)
Figure Astellas Pharma Inc. ALL Vaccine Sales Growth Rate (%) (2012-2017)
Figure Astellas Pharma Inc. ALL Vaccine Sales Market Share (%) in North America (2012-2017)
Figure Astellas Pharma Inc. ALL Vaccine Revenue Market Share (%) in North America (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of ALL Vaccine
Figure Manufacturing Process Analysis of ALL Vaccine
Figure ALL Vaccine Industrial Chain Analysis
Table Raw Materials Sources of ALL Vaccine Major Players/Manufacturers in 2015
Table Major Buyers of ALL Vaccine
Table Distributors/Traders List
Figure United States ALL Vaccine Sales (K Units) and Growth Rate (%) Forecast (2017-2022)
Figure United States ALL Vaccine Revenue (Million USD) and Growth Rate (%) Forecast (2017-2022)
Figure United States ALL Vaccine Price (USD/Unit) Trend Forecast (2017-2022)
Figure Canada ALL Vaccine Sales (K Units) and Growth Rate (%) Forecast (2017-2022)
Figure Canada ALL Vaccine Revenue (Million USD) and Growth Rate (%) Forecast (2017-2022)
Figure Canada ALL Vaccine Price Trend Forecast (2017-2022)
Figure Mexico ALL Vaccine Sales (K Units) and Growth Rate (%) Forecast (2017-2022)
Figure Mexico ALL Vaccine Revenue (Million USD) and Growth Rate (%) Forecast (2017-2022)
Figure Mexico ALL Vaccine Price (USD/Unit) Trend Forecast (2017-2022)
Table North America ALL Vaccine Sales (K Units) Forecast by Type (2017-2022)
Figure North America ALL Vaccine Sales (K Units) Forecast by Type (2017-2022)
Figure North America ALL Vaccine Sales (K Units) Forecast by Type in 2022
Table North America ALL Vaccine Sales (K Units) Forecast by Application (2017-2022)
Figure North America ALL Vaccine Sales (K Units) Forecast by Application (2017-2022)
Figure North America ALL Vaccine Sales (K Units) Forecast by Application in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Refer to Data Table Tab
the United States ALL Vaccine market is valued at XX USD million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

The Canada ALL Vaccine market is valued at XX USD million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

And Mexico ALL Vaccine market is valued at XX USD million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits North America into three countries, with sales (volume), revenue (value), market share and growth rate of ALL Vaccine in these regions, from 2012 to 2022 (forecast), covering
United States
Canada
Mexico


The major players in North America market include Pfizer, Inc., Glaxosmithkline, PLC., Merck & Co., Inc., Novarits, Sanofi Pasteur, CSL Limited, Emergent Biosolutions, Inc., Johnson & Johnson, Medimmune, LLC. (A Subsidiary of Astrazeneca), Astellas Pharma Inc., Mitsubishi Tanabe, Dynavax Technologies, Novavax

On the basis of product, the ALL Vaccine market is primarily split into
Vaccinia
Measles, mumps, rubella
Varicella
Influenza
Rotavirus
Zoster
Yellow Fever
Polio
Hepatitis A
Rabies
BCG
Diphtheria, tetanus
Hepatitis B
Haemophilus influenzae type b
Pertussis
Human papillomavirus
Meningococcal
Pneumococcal


On the basis on the end users/applications, this report covers
For Adult
For Child